FibroBiologics seeks US FDA patent for generation of three-dimensional organoids using fibroblast cell-based technology: Houston Saturday, September 14, 2024, 17:00 Hrs [IST] Fibr ...

The leading biopharmaceutical company is focused on developing and commercializing fibroblast cell-based therapies.

Imagine trying to poke a hole in the yolk of a raw egg without breaking the egg white. It sounds impossible, but researchers ...

Chief Scientific Officer, Hamid Khoja, Ph.D., to provide update on Psoriasis and Wound Care programsHOUSTON, Sept. 30, 2024 (GLOBE NEWSWIRE) -- FibroB (Nasdaq: FBLG) (“FibroBiologics”), a ...

As people age, more patients are developing heart failure. A study from Nagoya University found that an enzyme called PKN is ...

The Norman Lab aims to combine large-scale functional genomics experiments with computational modeling to enable rational engineering of cell state. Our primary model system is the fibroblast, a ...

Our research focuses on the tumor-permissive molecular mechanisms underlying cancer-associated fibroblast function as well as immune suppression, and how these stromal mechanisms affect cell fate and ...

“This patent, if issued, will allow us to pursue the development of a versatile ... and potential cures for chronic diseases using fibroblast cells and fibroblast-derived materials.

suggests that transforming growth factor β (TGF-β) and platelet-derived growth factor (PDGF) act synergistically to direct synovial fibroblasts toward a more aggressive phenotype in response to ...

Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company announced today that its LEGION Hinged Knee (HK) ...